Former executives of device maker Zynex Medical indicted for fraud
A federal grand jury in Rhode Island has recently indicted two former executives of pain management device company Zynex Medical on multiple counts of health care fraud. The indictment alleges that between 2017 and 2025, former CEO Thomas Sandgaard and COO Anna Lucsok engaged in fraudulent activities to secure millions of dollars from government and commercial insurers, as well as patients. Additionally, the indictment claims that the two individuals defrauded investors by concealing that the company’s revenues were obtained through fraudulent means.
United States Attorney Charles Calenda expressed concern over the case, stating, “This case represents a troubling abuse of patients seeking care, as well as the federal healthcare benefit system.”
The allegations against Sandgaard and Lucsok highlight the importance of maintaining integrity and transparency in the healthcare industry. Fraudulent activities not only harm patients and insurers but also erode trust in the system as a whole. It is essential for companies and executives to uphold ethical standards and adhere to regulations to ensure the well-being of patients and the integrity of the healthcare system.
As this case unfolds, it serves as a reminder of the consequences of fraudulent behavior in the healthcare sector. The indictment of these former executives underscores the need for vigilance and accountability in the industry to prevent similar incidents in the future. It is crucial for all stakeholders, including government agencies, insurers, healthcare providers, and patients, to remain vigilant and report any suspicious activities to uphold the integrity of the healthcare system.
